[A compact microarray for sub-typing of influenza A virus]

Area of Science:

• Biotechnology
• Virology
• Microfluidics

Context:

• Influenza A virus poses a significant global health threat, necessitating rapid and accurate subtyping for effective disease control and vaccine development.
• Current influenza subtyping methods can be time-consuming and require specialized laboratory equipment.
• The development of rapid, point-of-care diagnostic tools is crucial for timely intervention during influenza outbreaks.

Purpose:

• To develop and validate a universal oligonucleotide hybridization microchip for the simultaneous detection and subtyping of influenza A virus.
• To create a high-throughput biosensor capable of identifying all known hemagglutinin (HA) and neuraminidase (NA) subtypes of influenza A.
• To establish a cost-effective and efficient platform for influenza A virus surveillance and diagnostics.

Summary:

• A 6x5 spot (4x4 mm) oligonucleotide hybridization microchip was designed based on the principle of 'one spot-one subtype'.
• This microchip functions as a prototype biosensor for the detection of influenza A virus.
• It enables the typing of 15 hemagglutinin (HA) and 9 neuraminidase (NA) subtypes with integrated printing quality control.

Impact:

• This technology offers a potential for rapid, sensitive, and specific influenza A virus subtyping, aiding in epidemiological surveillance and pandemic preparedness.
• The microchip-based biosensor could facilitate decentralized influenza diagnostics, improving accessibility in resource-limited settings.
• Successful implementation could lead to faster identification of circulating influenza strains, informing public health interventions and vaccine strain selection.